Recent advances in bulbar syndromes: genetic causes and disease mechanisms

被引:12
|
作者
Manole, Andreea
Fratta, Pietro
Houlden, Henry
机构
[1] Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England
[2] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Brown-Vialetto-Van Laere syndrome; bulbar syndromes; Fazio-Londe syndrome; riboflavin supplementation; riboflavin transporter; SLC52A2; SLC52A3; VIALETTO-VAN-LAERE; MOTOR-NEURON DISEASE; HEREDITARY SPASTIC PARAPLEGIA; PRIMARY LATERAL SCLEROSIS; FAZIO-LONDE-DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; RIBOFLAVIN TRANSPORTER; VANLAERE-SYNDROME; MUSCULAR-ATROPHY; PONTOBULBAR PALSY;
D O I
10.1097/WCO.0000000000000133
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review With advances in next-generation gene sequencing, progress in deep phenotyping and a greater understanding of the pathogenesis of motor neuron disease, our knowledge of the progressive bulbar syndromes has significantly increased in recent years. This group of heterogeneous conditions, in which the primary disorder is focused around degeneration of the lower cranial nerves, can occur in children or adults and form a spectrum of severity, based around the common feature of bulbar dysfunction. Early genetic diagnosis may allow treatment in some bulbar syndromes. Recent findings Brown-Vialetto-Van Laere and Fazio-Londe syndromes are the most recent childhood forms of progressive bulbar palsy to be genetically defined. The clinical phenotype of this group of childhood disorders was first reported over 120 years ago. Recently, it was demonstrated that in a third of these patients Brown-Vialetto-Van Laere is caused by mutations in the SLC52A2 and SLC52A3 genes, both of which encode riboflavin transporters. Importantly, supplementation of riboflavin can lead to significant clinical improvement if started early in the disease process. Summary Here, we outline the clinical features, management and an update on the disease mechanisms and genetic causes of the progressive bulbar syndromes.
引用
收藏
页码:506 / 514
页数:9
相关论文
共 50 条
  • [1] The impact of recent advances in genetics in understanding disease mechanisms underlying the long QT syndromes
    Harmer, Stephen C.
    Tinker, Andrew
    BIOLOGICAL CHEMISTRY, 2016, 397 (07) : 679 - 693
  • [2] Overview of aldosterone-related genetic syndromes and recent advances
    Zennaro, Maria-Christina
    Fernandes-Rosa, Fabio L.
    Boulkroun, Sheerazed
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (03) : 147 - 154
  • [3] Advances in the genetic mechanisms of mitochondrial disease
    Vladutiu, GD
    CURRENT OPINION IN NEUROLOGY, 1997, 10 (06) : 512 - 518
  • [4] Recent advances in the understanding of genetic causes of congenital heart defects
    Gelb, BD
    FRONTIERS IN BIOSCIENCE, 2000, 5 : D321 - D333
  • [5] Recent advances in the understanding of genetic causes of congenital heart defects
    Gelb, BD
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 1999, 18 (06): : 501 - 527
  • [6] History, genetic, and recent advances on Krabbe disease
    Graziano, Adriana Carol Eleonora
    Cardile, Venera
    GENE, 2015, 555 (01) : 2 - 13
  • [7] Mechanisms of Disease: genetic causes of familial hypercholesterolemia
    Anne K Soutar
    Rossi P Naoumova
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 214 - 225
  • [8] Mechanisms of Disease: genetic causes of familial hypercholesterolemia
    Soutar, Anne K.
    Naoumova, Rossi P.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (04): : 214 - 225
  • [9] Myelodysplastic syndromes: recent advances
    Alessandrino, EP
    Amadori, S
    Cazzola, M
    Locatelli, F
    Mecucci, C
    Morra, E
    Saglio, G
    Visani, G
    Tura, S
    HAEMATOLOGICA, 2001, 86 (11) : 1124 - 1157
  • [10] Recent advances in myelodysplastic syndromes
    Shadduck, Richard K.
    Latsko, Joan M.
    Rossetti, James M.
    Haq, Bushra
    Abdulhaq, Haifaa
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (04) : 137 - 143